These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications. Baptista MJ; Tapia G; Muñoz-Marmol AM; Muncunill J; Garcia O; Montoto S; Gribben JG; Calaminici M; Martinez A; Veloza L; Martínez-Trillos A; Aldamiz T; Menarguez J; Terol MJ; Ferrandez A; Alcoceba M; Briones J; González-Barca E; Climent F; Muntañola A; Moraleda JM; Provencio M; Abrisqueta P; Abella E; Colomo L; García-Ballesteros C; Garcia-Caro M; Sancho JM; Ribera JM; Mate JL; Navarro JT Histopathology; 2022 Dec; 81(6):826-840. PubMed ID: 36109172 [TBL] [Abstract][Full Text] [Related]
11. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma. Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902 [TBL] [Abstract][Full Text] [Related]
12. [Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas]. Gerhard-Hartmann E; Rosenwald A Pathologe; 2020 Nov; 41(6):574-581. PubMed ID: 32909092 [TBL] [Abstract][Full Text] [Related]
13. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Au-Yeung RKH; Arias Padilla L; Zimmermann M; Oschlies I; Siebert R; Woessmann W; Burkhardt B; Klapper W Br J Haematol; 2020 Sep; 190(5):753-763. PubMed ID: 32239695 [TBL] [Abstract][Full Text] [Related]
14. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Salaverria I; Martin-Guerrero I; Wagener R; Kreuz M; Kohler CW; Richter J; Pienkowska-Grela B; Adam P; Burkhardt B; Claviez A; Damm-Welk C; Drexler HG; Hummel M; Jaffe ES; Küppers R; Lefebvre C; Lisfeld J; Löffler M; Macleod RA; Nagel I; Oschlies I; Rosolowski M; Russell RB; Rymkiewicz G; Schindler D; Schlesner M; Scholtysik R; Schwaenen C; Spang R; Szczepanowski M; Trümper L; Vater I; Wessendorf S; Klapper W; Siebert R; ; Blood; 2014 Feb; 123(8):1187-98. PubMed ID: 24398325 [TBL] [Abstract][Full Text] [Related]
15. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980 [TBL] [Abstract][Full Text] [Related]
16. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272 [TBL] [Abstract][Full Text] [Related]
17. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration. Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714 [TBL] [Abstract][Full Text] [Related]
19. Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience. Kuhlman JJ; Moustafa MA; Jiang L; Iqbal M; Seegobin K; Wolcott Z; Ayala E; Ansell S; Rosenthal A; Paludo J; Micallef I; Johnston P; Inwards D; Habermann T; Kharfan-Dabaja M; Witzig TE; Nowakowski GS; Tun HW Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e815-e825. PubMed ID: 35534379 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements]. Shen X; Zhou LT; Li AQ; Yi HM; Ouyang BS; Xu HM; Xie JL; Gu YJ; Zhang L; Dong L Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):120-125. PubMed ID: 35152630 [No Abstract] [Full Text] [Related] [Next] [New Search]